Sichenzia Ross Ference LLP

Author Archives: Sichenzia Ross Ference LLP

Sichenzia Ross Ference LLP is a full service law firm with a nationally recognized corporate, securities and litigation practice that provides experienced representation in all matters involving the securities industry.  In addition to handling routine to complex commercial matters, SRF’s renowned litigation department specializes in defending companies and individuals against all types of securities cases, including class action lawsuits, shareholder derivative actions, and matters involving allegations of fraud, misrepresentation or other securities violations.  The litigation team has also brought defamation lawsuits against companies and individuals related to market manipulation.  Additionally, it represents individuals and companies in investigations by the Securities and Exchange Commission (SEC) and other regulatory bodies.  The litigation team has a robust practice representing brokers and broker-dealers in arbitrations before the Financial Industry Regulatory Authority (FINRA).  These arbitrations typically involve claims of unsuitability, churning, unauthorized trading and other allegations of broker misconduct.  Finally, SRF has a burgeoning expungement practice, where it represents brokers seeking to have negative and harmful customer complaints removed from their industry records.  The firm complements its core practice areas with an established commercial real estate and trusts and estates practice. Visit SRF's LinkedIn page

SRF Founding Partner Gregory Sichenzia Featured in Authority Magazine Interview Series on Investing in Cannabis

Press Release — August 1, 2019 — New York, NY — Sichenzia Ross Ference LLP founding partner Gregory Sichenzia was interviewed by Len Giancola, as part of a series on investing in the cannabis industry for Authority Magazine. Authority Magazine frequently profiles thought-leaders and experts spanning multiple industries including business, film, sports and technology.

In his interview, Mr. Sichenzia shared stories and lessons learned from his career as well as tips and insights on what investors need to understand about the growing cannabis industry.

Please read the full Q&A here.

Sichenzia Ross Ference LLP Ranked as a Top Issuer Counsel for 2019 Q2  

Press Release – New York, NY – July 24, 2019 – PlacementTracker, part of the Business Intelligence Division of Informa PLC, has ranked Sichenzia Ross Ference LLP among the most active issuer counsels in the U.S. PIPE and private placement markets for the second quarter of 2019 by the number of transactions, representing issuers in over $50 million of placed securities.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $1.35 Million Underwritten Public Offering of ADSs of Immuron Limited

immuron logo

Press Release – New York, NY – July 23, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, as sole book runner in a $1.35 million Public Offering of the ADSs of Immuron Limited (NASDAQ “IMRN” ASX.”IMC”). The offering consisted of 339,130 ADS’s at a price of $4.00 per ADS for gross proceeds to the Company of $1.35 million. Immuron is an Australian biopharmaceutical company focused on oral immunoglobulin therapeutics. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia and Tara Guarneri-Ferrara.

continue reading >>

Sichenzia Ross Ference LLP Represents RealWear, Inc. in $80 Million Financing Transactions

realwear inc logo

Press Release — July 9, 2019 — New York, NY — Sichenzia Ross Ference LLP represented RealWear, Inc., an innovative technology company whose flagship product, the HMT-1®, is the first ruggedized head-mounted, wearable, Android-class tablet computer that frees a worker’s hands for dangerous jobs, in financing transactions raising an aggregate of $80 million. The Series B financing round was led by Teradyne, Inc. (TER), a global leader in industrial automation, and included participation from other industry leaders including Qualcomm Ventures and Bose Ventures. JPMorgan Chase & Co. acted as the exclusive placement agent to RealWear, Inc. in connection with the Series B financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Vuzix Corporation in $20 Million Registered Direct Offering

Vuzix Corporation

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of approximately 5.48 million registered shares of common stock at a price of $3.65 per share and approximately 5.48 million common stock purchase warrants with an exercise price of $4.10 per share  for gross proceeds to Vuzix of approximately $20 million. The Special Equities Group, a division of Bradley Woods & Co. Ltd. acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference LLP team was led by Partners Gregory Sichenzia, Tara Guarneri-Ferrara, and Counsel Jeff Cahlon.

Sichenzia Ross Ference Founding Partner Marc Ross Interviews with CFN Media on Business and Law of Marijuana

Press Release – New York, NY – July 8, 2019 – Sichenzia Ross Ference LLP founding partner Marc Ross participated in an interview with CFN Media to discuss the ever changing landscape of the Cannabis industry. The interview took place after an informative panel discussion about the Business and Law of Marijuana at the Cannabis World Congress Business Exposition at the Jacobs Javits Convention Center in New York City. Please find the full interview here.

Sichenzia Ross Ference LLP Represents Document Security Systems, Inc. in $5.6 Million Underwritten Public Offering of Common Stock

document security systems logo

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented its client, Document Security Systems, Inc. (NYSE American: DSS), in a $5.6 million public offering of its common stock.  The offering consisted of 11.2 million shares of common stock at a price of $0.50 per share. Aegis Capital Corp. served as sole book running manager in connection with the offering. DSS is a leader in the anti-counterfeit, authentication and diversion protection technology space. The Sichenzia Ross Ference team was led by Partners Gregory Sichenzia, Darrin Ocasio, Tara Guarneri-Ferrara and Jeffrey D’Angelo.

New Jersey Bureau of Securities Proposes New Rule to Create State-Level Fiduciary Duties For Broker-Dealers, Associated Persons, Investment Advisers and Investment Adviser Representatives

On April 15, 2019, the New Jersey Bureau of Securities, within the Division of Consumer Affairs, proposed a new state-level rule requiring all registered financial services professionals to act in accordance with the fiduciary duty to their customers when providing investment advice or recommending to a customer an investment strategy, the opening of or transfer of assets of any type of account, or the purchase, sale, or exchange of any security. Under the proposed rule, any conduct falling short of this fiduciary duty would constitute a “dishonest and unethical practice.”

Under current federal standards, only investment advisers subject to the Investment Advisors Act of 1940 and their representatives operate subject to a fiduciary duty standard. Among other differences from their investment adviser counterparts, broker-dealers and their associated persons typically receive only commissions for transactions they facilitate and for selling financial products – not compensation for financial planning, discretionary trading or investment portfolio advice and management. New Jersey proposes a substantial expansion of regulatory requirements on broker-dealers and their associated persons conducting business within the State of New Jersey.

The Proposed Rule

Dishonest or Unethical Practices

The proposed regulation, N.J.A.C. 13:47A-6.3 and N.J.A.C. 13:47A-6.4, seeks to impose a uniform, state-level duty of care and loyalty for both investment advisers and their representatives as well as broker-dealers and their associated persons doing business within the State. The State’s proposal is a product of its dissatisfaction with the pace of meaningful change to the federal regulatory framework following the United States Department of Labor’s failed Fiduciary Rule* and the scope of the United States Securities and Exchange Commission’s proposed Regulation Best Interest**, to promulgate a new, uniform federal interest ahead of the customer’s interest; (ii) act with diligence, care, skill and prudence; and (iii) disclose and mitigate, or eliminate, material conflicts of interest arising from financial incentives associated with the recommendation. Regulation Best Interest does not apply a fiduciary standard to broker-dealers or its associated persons. In addition, Regulation Best Interest allows some duty of loyalty conflict of interests to be mitigated through disclosure to the customer.

Expanded Reach and Duration

As proposed, the fiduciary duty would apply to recommendations to purchase, sell or hold securities and to recommendations about investment strategy, the opening of an account or the transfer of assets to any type of account. Further, the new duty would also apply to contractual and discretionary fiduciaries in addition to investment advice fiduciaries. Moreover, if investment advice is provided, the new fiduciary duty rule would impose an ongoing fiduciary duty for the entire relationship. In other words, dual registered persons who provide both brokerage recommendations and investment advice to a retail customer would be subject to the fiduciary duty for the life of the relationship***

Creating New and Rejecting Old Presumptions

The proposed rule also creates a new presumption that the investment adviser, its representative, the broker-dealer or its associated person breaches the duty of loyalty for any recommendation concerning the opening of, or transfer of assets to a specific type of account, or the purchase, sale or exchange of a specific security “that is not the best of the reasonably available options.” According to the State, the payment of transaction-based fees to broker- dealers or associated persons will not itself be deemed a breach of fiduciary duty, however, so long as “the fee is reasonable and is the best of the reasonably available fee options and the duty of care is satisfied.”

The regulation, if adopted in current form, disallows a presumption that disclosing a conflict of interest satisfies the duty of loyalty.

The proposed regulation applies to retail customer only, i.e., not banks, savings and loan associations, insurance companies, investment advisers, broker-dealers, fiduciaries to employee benefit plans, its participants or beneficiaries, or individuals with at least $50 million in assets.

Books and Records Requirements

Ostensibly to avoid federal preemption, the State’s proposal does not require any new or additional capital, custody, margin, financial responsibility, making and keeping of records, bonding or financial or operational reporting requirements on broker-dealers beyond those already required by federal law.

**********

If you have any questions about the issues addressed in this Broker-Dealer Regulation Alert, if you would like a copy of any of the materials mentioned in it or if you would like to continue to receive Broker-Dealer Regulation Alerts, please do not hesitate to call or email Securities and Commercial Litigation and Securities Regulatory Practice Partner Daniel Scott Furst at (646) 810-2185 or sfurst@srf.law ****

*The Department of Labor’s rule was to be implemented starting April 10, 2017, however, on or about June 21, 2018, the United States Fifth Circuit Court of Appeals vacated the rule, effectively killing it.

***Broker-dealer associated persons who act in a broker-only capacity, however, would be subject to the fiduciary duty only through the transaction’s execution.

**The final rulemaking of Regulation Best Interest was approved in a 3-to-1 vote by the Commission on June 5, 2019. Regulation Best Interest is effective 60 days after publication in the Federal Register, and the anticipated implementation date is June 30, 2020. Regulation Best Interest would create a national, heightened standard of conduct for broker-dealers. Regulation Best Interest provides that when a broker- dealer or its associated person recommends securities transaction or investment strategy, the broker-deal or associated person must: (i) act in the customer’s best interest, without placing its financial or other standard applicable to investment advisers and broker-dealers. Specifically, the proposed regulation would define a “dishonest or unethical practice” to include: recommending to a customer, an investment strategy, the opening of, or transfer of any assets to, any type of account, or the purchase, sale, or exchange of any security or securities without reasonable grounds to believe that such strategy, transaction, or recommendation is suitable for the customer based upon reasonable inquiry concerning the customer’s investment objectives, financial situation, and needs, and any other relevant information known by the broker-dealer[.]

****This Broker-Dealer Regulation Alert is for general information purposes only of interest to New Jersey broker-dealers and is not intended to advertise our services, solicit clients or represent our legal advice.

daniel scott furst

Sichenzia Ross Ference LLP Represents Medicine Man Technologies, Inc. in Private Placement Offering of up to $14 Million

medicine man technologies

Press Release – New York, NY – June 10, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Medicine Man Technologies, Inc. (OTC: MDCL) (“Medicine Man or the “Company”) in a securities purchase agreement with Dye Capital & Co. for the sale of up to $14 million of shares and common stock purchase warrants of the Company. The shares were sold at a price of $2.00 per share.

continue reading >>

Sichenzia Ross Ference LLP Represents FINRA Member Firm in $3.0 Million Registered Direct Offering of Common Stock and Warrants of General Cannabis Corp.

Press Release­­ – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that it has represented a FINRA member firm as financial advisor in the registered direct offering of 3.0 million shares of common stock and 3.0 million warrants of General Cannabis Corp. (OTCQX: CANN) at a price of $1.00 per share for gross proceeds of approximately $3.0 million.

continue reading >>

Sichenzia Ross Ference LLP Represents AIT Therapeutics in $8 Million Private Placement

AIT therapeutics

Press Release – New York, NY – June 4, 2019 – Sichenzia Ross Ference LLP announced today that it has represented AIT Therapeutics, Inc. (NASDAQ:AITB), a clinical-stage medical device and biopharmaceutical company focused on developing inhaled Nitric Oxide (NO) for the treatment of patients with respiratory conditions including serious lung infections and pulmonary hypertension, in a $8 million private placement of its common stock.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $8.0 Million Public Offering of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP (SRF) announced today that it has represented Aegis Capital Corp. as sole book-running manager in the underwritten public offering of 1.66 million shares Common Stock of Medalist Diversified REIT, Inc.(NASDAQ: MDRR) at a price of $4.80 per share for gross proceeds of $8.0 million.

continue reading >>

Sichenzia Ross Ference LLP Announces $1.3 million Private Placement of Common Stock of Medalist Diversified REIT, Inc.

medalist diversified logo

Press Release – New York, NY – May 31, 2019 –  Sichenzia Ross Ference LLP announced today that it has represented Aegis Capital Corp. as placement agent in a private offering of 270,833 shares of Common Stock of Medalist Diversified REIT, Inc. (NASDAQ: MDRR) at a purchase price of $4.80 per share for gross proceeds of approximately $1.3 million.

continue reading >>

Sichenzia Ross Ference Litigation Partners Marc Ross and Scott Furst Prevail on Multiple Appeals on Behalf of Client in a Multi-Year Southampton Property Dispute

Press Release – New York, NY – May 30, 2019 – Sichenzia Ross Ference LLP (SRF) litigation partners Marc Ross and Scott Furst, together with appellate counsel, prevailed on multiple appeals taken to the Supreme Court New York, Appellate Division: Second Judicial Department.  The appeals sought to reverse a Suffolk County trial court’s denial of a motion to dismiss a lawsuit commenced in 2015 by adjacent property owners who sought and were awarded by the trial court injunctive relief halting an ongoing, residential construction overlooking Shinnecock Bay, in the Town of Southampton.  An earlier, related litigation concerning the property and its compliance with the local zoning laws relating to height and setback requirements, ultimately failed to resolve the dispute and gave rise to the instant lawsuit at which time SRF was engaged by the Appellant to take over the litigation.

continue reading >>

Sichenzia Ross Ference LLP Represents ThinkEquity in $2.0 Million Underwritten Public Offering of ADSs of Immuron Limited.

immuron logo

Press Release – New York, NY – May 29, 2019 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a Division of Fordham Financial Management, Inc. as sole book runner in a $2.0 million Public Offering of American Depositary Shares (ADSs) of Immuron Limited (ASX: “IMC”; NASDAQ “IMRN”).

continue reading >>

Sichenzia Ross Ference LLP Represents Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE) in Offering of $1.2 Million American Depositary Shares

genetic technologies logo

Press Release – New York, NY – May 23, 2019 –  Sichenzia Ross Ference LLP announced today that it represented Genetic Technologies Limited (ASX: GTG; Nasdaq: GENE), a diversified molecular diagnostics company, in a registered direct offering of American Depositary Shares (“ADSs”) and warrants to purchase ADSs.  The Company received gross proceeds of approximately $1,200,000.

continue reading >>

Founding Partner Marc Ross Publishes Op-Ed on Business and Legality of CBD

New York, NY – May 10, 2019 – Sichenzia Ross Ference LLP (SRF) announced today that founding partner Marc Ross published an opinion piece on the business and legality of CBD. The piece, titled “Sorting Out the Confusion Regarding CBD,” was featured on Aeroflow Naturals’ education blog, a resource center for all things CBD.

Aeroflow Naturals is a leading provider of CBD and a subsidiary of Aeroflow Healthcare, a premier provider of durable medical equipment (DME) and services in the Southeastern United States.
You can read the full article here.

Sichenzia Ross Ference LLP Congratulates AIT Therapeutics, Inc. on NASDAQ Uplisting

New York, NY – May 9, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented AIT Therapeutics, Inc. (NASDAQ: AITB), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Gregory Sichenzia and partner Avital Perlman. The uplisting is effective for trading on May 7, 2019, and AITB’s common stock will trade under its existing stock symbol, “AITB.”

continue reading >>

Litigation Partner Scott Furst Successfully Defeats Appeal In $10,000,000 Insurance Dispute

Press Release – New York, NY – May 9, 2019 – Sichenzia Ross Ference LLP (SRF) litigation partner Scott Furst successfully defeated an appeal taken to the Supreme Court New York, Appellate Division: Second Judicial Department, which sought to vacate a trial court’s complete dismissal of a multi-party, multi-claim lawsuit for damages and to rescind and restore approximately ten million dollars of insurance coverage ($10,000,000.00).  Plaintiffs brought claims that included fraud, breach of contract and violations of the New York State Insurance Law against an insurance agent, insurance agency and insurer.  Plaintiffs commenced their lawsuit in July 2014 and, during almost five years of litigation, Mr. Furst, on behalf of the agent and agency, successfully moved to dismiss the original complaint, defeated a motion to renew and reargue and moved to dismiss the amended complaint from which the appeal was taken.  The Second Department denied the appeal on multiple grounds giving particular emphasis to the Defendants’ evidence that contradicted the Plaintiffs’ allegations.  The Court also concluded that Plaintiffs could not, as a matter of law, state claims against the agent or agency.  Relying on the facts and law presented by SRF, the Second Department also affirmed the trial court granting summary judgment in favor of the insurer and against the Plaintiffs, which was also appealed.

Odierna v. RSK, LLC, 2019 N.Y. App. Div. LEXIS 2573 (2d Dep’t 2019).

daniel scott furst

Sichenzia Ross Ference LLP Celebrates its 21st Anniversary

Press Release – New York, NY – May 7, 2019 –  Originally founded on May 5, 1998, Sichenzia Ross Ference LLP celebrates its 21st year of legal excellence and service for its diverse range of clientele.  From its original three founding attorneys SRF has grown to a family of 65 people who remain dedicated to the highest level of legal counsel spanning a number of industries, including but not limited to securities, corporate, real estate, cannabis, trust & estates, litigation and several others.

Founding Partner Marc Ross Participates in Panel Discussion on Legal Cannabis

Press Release – New York, NY – April 25, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, today announced that founding partner Marc Ross participated in a panel discussion on the future of the legal cannabis industry. The discussion was featured in a recent episode of “Innovators with Jane King,” an interview series hosted by Nasdaq.

A video of the full discussion can be found here: https://www.youtube.com/watch?v=OUtVZfF-_b0

Founding Partner Gregory Sichenzia Quoted in Article on How to Determine if Your Company is IPO Ready

Press Release – New York, NY – April 24, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, shared today that founding partner Gregory Sichenzia was recently featured in an article on YouInc, an online resource for entrepreneurs and business owners.

Greg spoke with reporter Jordan Rosenfield to share insights on when companies should consider an initial public offering (IPO).

Sichenzia Ross Ference Closes $180 Million Real Estate Portfolio Acquisition on Behalf of Client

Press Release – New York, NY – April 22, 2019Sichenzia Ross Ference LLP, a leading corporate securities and full service law firm, today announced that it recently closed on an approximately $180 million multifamily real estate portfolio acquisition for one of its clients, a dynamic and growing real estate investment firm.  This complex transaction involved the acquisition of several REIT entities, negotiation of a preferred equity JV component and a multi-million-dollar debt facility on the portfolio of assets.  The Sichenzia Ross Ference LLP team was led by Real Estate partner Anthony Ficara, partner Mendy Piekarski and counsel Michael Wickersham.

continue reading >>

Sichenzia Ross Ference LLP Represents Quest Solutions, Inc. in $5 Million Private Placement

quest solution

Press Release – New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that it has represented Quest Solution, Inc.  (OTCQB: QUES) in the private placement of 16,666,667 unregistered shares of its common stock, at a purchase price of $.30 per share, for gross proceeds of approximately $5,000,000. Investors also received warrants to purchase 16,666,667 shares of common stock at an exercise price of $.35 per share.

continue reading >>

Sichenzia Ross Ference LLP Congratulates INmune Bio Inc., on Initial Public Offering

New York, NY – April 9, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented INmune Bio Inc. (NASDAQ: INMB), in the Company’s Initial Public Offering and subsequent listing on the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Marc Ross and partners David Manno and Thomas Rose. The stock became effective for trading on February 4, 2019, and its common stock trades under the symbol, “INMB.”

Follow Sichenzia Ross Ference on Twitter: @SichenziaRoss

 

 

Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $25 Million Credit Facility with East West Bank

new age beverage corp. logo

Press Release – New York, NY – April 2, 2019 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a loan and security agreement with East West Bank which provides for up to $25 million aggregate principal amount revolving credit facility, which includes a $15 million term loan and a feature to provide an additional $10 million should the company choose to utilize it and a $10 million revolving line of credit.

continue reading >>

Sichenzia Ross Ference LLP Announces its Platinum-Level Sponsorship of the 2019 ThinkEquity Conference

Press Release – New York, NY – March 29, 2019 – Sichenzia Ross Ference LLP is happy to announce its Platinum-Level sponsorship for the 2019 ThinkEquity Conference. The conference will be held on May 2, 2019 at The Mandarin Oriental Hotel in New York, NY.

Gregory Sichenzia, one of SRF’s founding partners, commented, “We have long been friends of ThinkEquity and are excited to support its growing conference series.”

Sichenzia Ross Ference LLP Represents LiveWell Canada Inc. in $15 Million Private Placements to Scale its CBD Operations

live well

Press Release – New York, NY – March 28, 2019 – Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that it represented LiveWell Canada Inc. (“LiveWell”), a Canadian CBD company listed on the Canadian Stock Exchange entering the U.S. markets, in a private placement offering of senior secured convertible notes with institutional investors for total aggregate gross proceeds of $15 million, which includes LiveWell’s previously closed $3 million bridge financing.

continue reading >>

Sichenzia Ross Ference LLP Represents Aegis Capital Corp. in $5.4 Million Public Offering of Common Stock of Opgen, Inc.

opgen logo

Press Release – New York, NY – March 28, 2019 –  Sichenzia Ross Ference  LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of 9 million shares Common Stock of Opgen, Inc. (NASDAQ: OPGN) at a price of $.60 per share for gross proceeds of $5.4 million.  Opgen is a precision medicine company harnessing the power of molecular diagnostics to combat infectious disease. The Sichenzia Ross Ference LLP team was led by partners Tom Rose, Gregory Sichenzia and Jay Yamamoto.

Sichenzia Ross Ference LLP

Sichenzia Ross Ference Represents Pareteum Corporation in $50 Million Credit Facility with Post Road Group

The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

Press Release – New York, NY – March 20, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a global cloud software communications platform company, as it closed a $50,000,000 committed senior secured credit facility with Post Road Group. Under the terms of the credit facility, Post Road provided Pareteum an initial loan of $25,000,000 on February 26, 2019, with additional loans in increments of $5,000,000 to be made as requested by Pareteum before the 18-month anniversary of the initial funding date.

The Sichenzia Ross Ference LLP team was led by partners Darrin Ocasio and Avital Perlman and associates Grant Levine and Huan Lou.

Sichenzia Ross Ference LLP

Founding Partner Marc Ross to Present Legal Webinar on The Conflicting State and Federal Laws Concerning Marijuana, Hemp and CBD

Press Release – New York, NY – March 11, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that its founding partner Marc J. Ross will present a webinar course at the Clear Law Institute, “The Interplay Between State Laws Legalizing Recreational and/or Medical Marijuana Uses and the Federal Controlled Substance Act,” on Monday, March 11, 2019 at 3:00 pm.

continue reading >>

Will The Murky Marijuana Banking Picture Finally Get Clearer?

Federal Reserve Chairman Jerome Powell, while testifying before Congress yesterday, Tuesday, February 26, 2019, explicitly acknowledged the uncertainty and tension surrounding the access of a company engaged in marijuana or marijuana-related business to banking because of conflicting state and federal laws.  When asked about the topic, the Chairman said, “I think it would be great to have clarity,” adding, “Financial institutions and their regulators and supervisors are in a difficult position with marijuana being illegal under federal law and legal under some state laws.”

Further, last week, the House Financial Services Committee made history by holding its first ever hearing on marijuana and financial services. Up for discussion at that hearing was a new draft of the Secure and Fair Enforcement (SAFE) Banking Act.  Last year, Congress introduced the SAFE Act of 2017, which stalled and went nowhere.  Colorado Rep. Ed Perlmutter, a prime sponsor of the bill, has been introducing a version of this bill for almost six years, but has failed to get a hearing until now. This year, not only is the bill going to be discussed, but the bill is even more robust, specifically adding protections for ancillary businesses providing products and services to marijuana-related businesses.

As Treasury Secretary Steven Mnuchin made clear while testifying before Congress last year, he too would like to see marijuana businesses able to access banking services.  “I assure you that we don’t want bags of cash,” he said before a House Committee last year.  “We want to find a solution to make sure that the businesses that have large access to cash have a way to get them into a depository institution for it to be safe.”

Today, while 10 states and the district of Columbia have legalized recreational marijuana, marijuana remains illegal on the federal level, listed as a Schedule 1 drug, along with heroin and LSD.  And, while an increasing number of financial institutions are willing to bank marijuana and marijuana-related businesses, there still is a predominant, industry-wide reluctance to get involved, whether because of the added compliance that is required, or because of the unclear restrictions that are promulgated, by the Department of the Treasury.

Marc J. Ross, Esq.
Latest posts by Marc J. Ross, Esq. (see all)

    Sichenzia Ross Ference Represents Pareteum Corporation in Tender Offer for Shares of iPass, Inc. and Completes Acquisition

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    Press Release – New York, NY – February 14, 2019 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it accepted for exchange shares  of iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity.

    continue reading >>

    Sichenzia Ross Ference Partner Ralph Preite Participates on Financial Poise’s “Legal Ethics – Best Practices Regarding Technology” Webinar

    Press Release – New York, NY – February 14, 2019 –  Sichenzia Ross Ference LLP Partner Ralph Preite participated on Financial Poise’s “Legal Ethics – Best Practices Regarding Technology” webinar, hosted on February 13th.

    This webinar series examines ethical issues confronted by businesses in a variety of contexts, from so called “grey areas” to those involving outright corruption. The panelists consider and recommend different approaches to ethical decision-making and the lawyer’s role in advising business clients.

    To learn more, please click here.

    Sichenzia Ross Ference LLP Adds Jeff D’Angelo as Corporate & Securities Partner

    NEW YORK, Feb. 13, 2019 (GLOBE NEWSWIRE) — Sichenzia Ross Ference, a leading securities and corporate law firm, announced today that Jeff D’Angelo will join the firm as a Partner in the firm’s Corporate and Securities practice, effective on February 19, 2019.

    Prior to joining SRF, Mr. D’Angelo worked with publicly-traded company Document Security Systems, Inc. in a variety of roles, including Vice-President and General Counsel. Prior to joining DSS, Mr. D’Angelo practiced corporate law for several years, and also served as Managing Director at Prudential Financial, heading its Western New York financial operation and overseeing more than 60 sales associates and managers.

    Mr. D’Angelo will represent SRF’s clients in securities law, corporate governance, commercial contracts, general corporate law, mergers & acquisitions, IPOs, technology licensing and corporate finance matters. In 2018, during his tenure as in-house general counsel for DSS, Mr. D’Angelo was nominated for the Western New York Daily Record and Rochester Business Journal’s Corporate Counsel of the Year Award.

    “Sichenzia Ross offers me the perfect transition from my role as in-house general counsel while providing an ideal platform for me to continue representing DSS as outside counsel under the SRF umbrella. I have known Greg Sichenzia for years, as we attended law school together and have collaborated professionally in the past, and I am excited to join a nationally-recognized corporate and securities law firm with such a diverse roster of innovative public company clients,” said Mr. D’Angelo. “I am confident that my experience coupled with Sichenzia Ross’ reputation for excellence will help me to continue to grow the firm’s national corporate practice.”

    Founding partner Gregory Sichenzia welcomed the addition, saying, “We are very glad to have Jeff on board. We worked with him when he was DSS’ general counsel and know that he has the professionalism and character that we seek to attract.”

    Mr. D’Angelo holds a B.S. in General Management from Purdue University, and a law degree from the Benjamin N. Cardozo School of Law.

    About Sichenzia Ross Ference LLP

    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference LLP Represents A.G.P/ Alliance Global Partners in $6.5 Million Public Offering for Cellect Biotechnology Ltd.

    cellect logo

    Press Release – New York, NY – February 12, 2019 –  Sichenzia Ross Ference LLP announced today that it represented A.G.P/ Alliance Global Partners as sole book running manager in the underwritten public offering of American Depository Shares (ADSs) and Warrants of Cellect Biotechnology Ltd., an Israeli biotech company (NASDAQ: APOP). National Securities Corporation and Dawson James Securities, Inc. acted as co-managers for the offering.

    continue reading >>

    Sichenzia Ross Ference LLP Congratulates Zynex, Inc., on NASDAQ Uplisting

    New York, NY – February 8, 2019 – Sichenzia Ross Ference LLP announced today that the firm represented Zynex, Inc. (NASDAQ: ZYXI), in the Company’s uplisting to the NASDAQ Capital Market. The Sichenzia Ross Ference LLP team was led by founding partner Gregory Sichenzia and partner Tara Guarneri-Ferrara. The up-listing is effective for trading on February 12, 2019, and ZYXI’s common stock will trade under its existing stock symbol, “ZYXI.”

    “We applaud ZYXI on the achievement of this important milestone, one that positions the Company’s to capitalize on its market objectives while it continues to develop its pain management and rehab electrotherapy devices,” said Gregory Sichenzia,  partner of Sichenzia Ross Ference LLP.

    Sichenzia Ross Ference LLP Represents INmune Bio Inc. in an $8 Million Initial Public Offering and Listing on the Nasdaq Capital Market

    inmunebio logo

    Press Release – New York, NY – February 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented INmune Bio Inc. (INMB), an immunotherapy company focused on developing therapies that harness the patient’s innate immune system to fight disease, in an initial public offering at a price of $8.00 per share resulting in gross proceeds of approximately $8,000,000 and listing on the Nasdaq Capital Market under the ticker symbol INMB.

    continue reading >>

    Sichenzia Ross Ference LLP Launches Cannabis Law Group

    Press Release – New York, NY – January 24, 2019 – Sichenzia Ross Ference LLP (“SRF”), a leading corporate securities and full service law firm, today announced that the firm has launched a specialty practice group devoted to servicing the legal needs of cannabis related businesses. SRF’s Cannabis Law Group is led by founding partner Marc J. Ross. The full release can also be found here.

    continue reading >>

    Sichenzia Ross Ference LLP Launches Merchant Cash Advance Practice Group

    NEW YORK, Jan. 15, 2019 — Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, today announced that the firm has launched a specialty practice group devoted to servicing the legal needs of alternative commercial financing and merchant cash advance (MCA) companies.

    Led by Sichenzia Ross Ference partner Mendy Piekarski, this multi-discipline group has established expertise in all aspects of the MCA business cycle, including capital formation, asset deployment, brokering arraignments, syndication and participation agreements, regulatory compliance, and litigation. continue reading >>

    Sichenzia Ross Ference LLP Represents Boulder Botanicals & Biosciences Laboratories, Inc. in a $5.0 Million Private Placement

    boulder botanicals

    Press Release – New York, NY – January 5, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, is pleased to announce that the firm has represented Boulder Botanicals & Biosciences Laboratories, Inc.  (BBBL), a holding company which owns and operates several companies operating within the CBD production, extraction and distribution industries in a private placement of shares of common stock at a price of $1.00 per share resulting in gross proceeds of approximately $5,000,000.

    continue reading >>

    Sichenzia Ross Ference LLP Represents Boustead Securities, LLC as Underwriter to China SXT Pharmaceuticals, Inc.’s $10.2 Million U.S. Initial Public Offering

    china sxt pharmaceuticals

    Press Release – New York, NY – January 4, 2019 – Sichenzia Ross Ference LLP congratulates China SXT Pharmaceuticals, Inc. (the “Company”) (NASDAQ: SXTC), a specialty pharmaceutical company focusing on the research, development, manufacture, marketing and sales of Traditional Chinese Medicine Pieces (“TCMPs”), on the final closing of its initial public offering on January 3, 2019. Together with the first closing on December 31, 2018, the Company raised approximately $10.2 million in gross proceeds, before deducting underwriting discounts, commissions and other offering expenses, by issuing 2,546,275 ordinary shares at a public offering price of $4.00 per share. The shares are scheduled to commence trading on the NASDAQ Capital Market today at around 2:05 p.m. ET under the ticker symbol “SXTC.”

    continue reading >>

    Sichenzia Ross Ference LLP Represents New Age Beverages Corporation in the $85 Million Acquisition of Morinda Holdings, Inc.

    new age beverage corp. logo

    NEW YORK, Jan. 03, 2019 — Sichenzia Ross Ference LLP, a leading securities and corporate law firm, announced today that its mergers and acquisitions team represented New Age Beverages Corporation (NASDAQ:NBEV) in its acquisition of Morinda Holdings, Inc., a Utah-based healthy beverages and lifestyle company with operations in more than 60 countries worldwide.

    The consideration for the merger was $85 million, comprised of $75 million in cash and $10 million paid in 2,016,480 shares of New Age common stock based on the 40-day volume-weighted average price calculated through December 20, 2018. The transaction was subject to the pre-merger notification requirements of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended and closed on December 21, 2018.

    The full Sichenzia Ross release can be found here.

    continue reading >>

    Sichenzia Ross Ference LLP Represents A.G.P/Alliance Global Partners in $10 Million Public Offering for Creative Realities, Inc.

    creative realities logo

    Press Release – New York, NY – November 19, 2018 –  Sichenzia Ross Ference LLP announced today that it has represented A.G.P/ Alliance Global Partners  (through Euro Pacific Capital) as sole book running manager in the underwritten public offering of shares of Common Stock and Warrants of Creative Realities, Inc. (NASDAQ: CREX).

    continue reading >>

    Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $52 Million Underwritten Public Offering

    new age beverage corp. logo

    Press Release – New York, NY – November 14, 2018 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in an underwritten public offering of 14,835,000 shares of its common stock, which includes a full simultaneous exercise of the underwriters 15% over allotment option, at a public offering price of $3.50 per share for gross proceeds to NBEV of $51,922,500. Roth Capital Partners and A.G.P/ Alliance Global Partners acted as joint book-running managers for the offering. Please click here to read the full Sichenzia Ross release.

    continue reading >>

    Sichenzia Ross Ference Represents Pareteum Corporation in Definitive Agreement to Acquire iPass, Inc.

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    Press Release – New York, NY – November 13, 2018 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference LLP announced today that it represented Pareteum Corporation (Nasdaq: TEUM), a cloud software platform, as it entered into a definitive agreement under which it will acquire iPass, Inc. (Nasdaq: IPAS), a provider of global mobile connectivity, in an all-stock transaction. Pareteum anticipates achieving more than $15 million in annual cost synergies; more than $12 million of such synergies are expected to be realized in the first year.

    continue reading >>

    Sichenzia Ross Ference LLP Represents Novume Solutions, Inc. in $3.3 Million Underwritten Public Offering of Common Stock

    novume logo

    Press Release – New York, NY – November 1, 2018 – Sichenzia Ross Ference LLP announced today that it has represented Novume Solutions, Inc. (NASDAQ “NVMM”) in a public offering of 4.125 million shares of its common stock at a price of $.80 per share for gross proceeds to the Company of $3.3 million.
    continue reading >>

    Sichenzia Ross Ference LLP Represents Wize Pharma, Inc. in a $4.45 Million Private Placement

    wize pharma

    New York, NY – October 24, 2018 – Sichenzia Ross Ference LLP, announced today that it represented Wize Pharma, Inc. (OTCQB: “WIZP”), a clinical stage Israel based U.S. public company focused on the treatment of ophthalmic disorders company, in a private placement with institutional and accredited investors  of 3,100,000 shares of common stock at $1.00 per share and 1,350 shares of newly created Series A preferred stock which is convertible at $1.00 per share.

    continue reading >>

    Founding Partner Gregory Sichenzia Quoted in Leading Law Trade Publications

    Press Release – New York, NY – January 14, 2019 – Sichenzia Ross Ference (“SRF”), a leading securities and corporate law firm, shared today that founding partner Gregory Sichenzia was featured in two leading law publications, Law.com and Law.360.

    In the Law.com article, Greg spoke with reporter Christine Simmons to share his insight on how the government shutdown may impact public companies and their legal counsel.

    In the Law360 article (subscription required), Greg spoke with Tom Zanki to discuss takeaways from the JP Morgan Healthcare conference in San Francisco.

    Sichenzia Ross Ference LLP Represents Rodman & Renshaw a Unit of H.C Wainwright in a $15 Million Upsized Public Offering of Medical Transcript Billing, Corp.

    mtbc.com logo

    Press Release – New York, NY – October 15,  2018 – Sichenzia Ross Ference LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

    continue reading >>

    Sichenzia Ross Ference LLP Represents New Age Beverages Corp. in $12 Million Credit Facility

    new age beverage corp. logo

    Press Release – New York, NY – August 24, 2018 – Sichenzia Ross Ference LLP announced today that it has represented New Age Beverages Corporation (NASDAQ “NBEV”) in a loan and security agreement with Siena Lending Group LLC which provides for a $12 million aggregate principal amount revolving credit facility, which is subject to availability based on eligible accounts receivables and eligible inventory of the Company.

    continue reading >>

    Sichenzia Ross Ference LLP Represents ThinkEquity, a division of Fordham Financial Management as Sole Book-Running Manager on $10 Million Public Offering of Securities of  FlexShopper, Inc.

    flexshopper

    Press Release – New York, NY – October 1, 2018 – Sichenzia Ross Ference LLP announced today that it has represented ThinkEquity, a division of Fordham Financial Management, Inc. as sole book-running manager in an underwritten public offering of $10 Million of Units of FlexShopper, Inc. (Nasdaq FPAY).

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corporation in a $4.75 Debt Transaction

    new age beverage corp. logo

    Press Release – New York, NY – June 20, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented New Age Beverages Corporation (“NASDAQ. NBEV”), a Colorado based organic and natural healthy beverage company in a $4.75 million senior secured convertible promissory note transaction. A portion of the proceeds were used to repay the Company’s line of credit with US Bank. The Company also converted debt held by Sunkist Growers, Inc. an agricultural marketing cooperative, into shares of its common stock.

    The Sichenzia Ross Ference Kesner LLP team was led by Partners, Gregory Sichenzia and Marcelle Balcombe and Of Counsel, Kimberly Boler.

    Sichenzia Ross Ference Kesner LLP Represents ThinkEquity, a Division of Fordham Financial Management as Sole Book-Running Manager on $18 Million Public Offering of Securities of Trovagene, Inc.

    trovagene logo

    Press Release – New York, NY – June 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented ThinkEquity, a division of Fordham Financial Management, Inc., as sole book-running manager on its first underwritten public offering since launching its new ThinkEquity division.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.1 Million Registered Direct Offering

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    New York, NY – May 14, 2018 – Nationally recognized securities and corporate law firm, Sichenzia Ross Ference Kesner LLP, announced today that it represented Pareteum Corporation (NYSE: TEUM), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a registered direct offering of 2,440,000 shares of common stock. The purchase price per share was $2.50. Pareteum received gross proceeds of $6.1 million.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Acolyte Group in the Sale of its LED Lighting Business to CapStreet Private Equity Group

    acolyte group

    May 2, 2018 — New York, NY.  Sichenzia Ross Ference Kesner LLP (“SRFK”) represented The Acolyte Group, a New York based provider of fully integrated LED lighting systems, in the sale of its entire business to General LED, a portfolio company of Houston, Texas based private equity firm Cap Street Group.

    The SRFK team was led by Partners Thomas Rose and Gregory Sichenzia and Counsel Jeff Cahlon with assistance from Counsel Todd Manister from the SRFK Real Estate Group.

    Sichenzia Ross Ference Kesner LLP Represents A.G.P/ Alliance Global Partners (through Euro Pacific Capital) in $8 Million Public Offering of Common Stock of Cocrystal Pharma, Inc.

    cocrystal pharma

    Press Release – New York, NY – May 3rd, 2018 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented A.G.P./Alliance Global Partners, offering securities through Euro Pacific Capital, in an underwritten public offering of shares of common stock of Cocrystal Pharma, Inc. (NASDAQ: COCP). Cocrystal sold an aggregate of 4,210,527 shares of common stock at a price of $1.90 per share. Cocrystal is a clinical stage biotechnology company discovering and developing novel antiviral therapeutics that target the replication machinery of hepatitis viruses, influenza viruses, and noroviruses.  The Sichenzia Ross Ference Kesner LLP team was led by partners Marc Ross, Avital Perlman and Tom Rose.

    Sichenzia Ross Ference Kesner LLP Represents Sunworks, Inc., in a $3.75 Million Debt Transaction

    sunworks solar power

    Press Release – New York, NY – April 27, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented Sunworks, Inc. (NASDAQ: SUNW), a premier provider of high performance solar power systems, in a $3.75 million two year term loan transaction. The lender is CrowdOut Capital LLC. Management, including the Chief Financial Officer, also participated in $750,000 of the loan amount.

    The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and Marcelle Balcombe.

    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference Kesner LLP Represents New Age Beverages Corp. in $4 Million Underwritten Public Offering

    new age beverage corp. logo

    Press Release – New York, NY – April 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented New Age Beverages Corp.  (NASDAQ: NBEV) in a public offering of 2,285,715 shares of its common stock at a price of $1.75 per share for gross proceeds to NBEV of $4,000,000. A.G.P/ Alliance Global Partners  (Euro Pacific Capital) and Maxim Group L.L.C. acted as the Joint Book Running Managers for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Marcelle Balcombe, and Counsel Jeff Cahlon.

    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a Unit of H.C Wainwright, in a  $10.5 Million Public Offering of Medical Transcript Billing, Corp.

    mtbc.com logo

    Press Release – New York, NY – April 11, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (NASDAQ: MTBC).

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents AYTU Bioscience, Inc., in $12 Million Public Offering

    aytu bioscience

    Press Release – New York, NY – March 6, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented AYTU Bioscience, Inc. (NASDAQ: AYTU) in a $12 million public offering of Class A Units, comprising common stock and warrants and Class B Units comprising Series B Preferred Stock and Warrants. A total of 19,520,000 Class A Units were sold at a price of $0.45 per unit and 3,216 Class B Units were sold at a price of $1,000 per unit.  The warrants are exercisable at a price of $0.54 per share for a term of 5 years. Joseph Gunnar & Co. acted as the Sole Book Running Managing Underwriter and Fordham Financial Management, Inc. acted as the Lead Managing Underwriter.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in a $5 Million Private Placement

    moneyonmobile-logo

    Press Release – New York, NY – February 12, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented MoneyOnMobile, Inc. (“MOMT”), a global mobile payments technology and processing company, in a private placement offering with accredited investors in which MOMT received $4,998,000 in consideration for the issuance of 1,666 shares of Series H Preferred Stock and a five year warrant to purchase 3,332,000 shares of common stock at an exercise price of $0.50 per share.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents MoneyOnMobile, Inc., in $7.6 Million of Private Placements

    moneyonmobile-logo

    Press Release – New York, NY – February 8, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it represented MoneyOnMobile, Inc. (“MOMT”), a global mobile payments technology and processing company, in a private placement offering with accredited investors where MOMT sold an aggregate of 5,567 shares of Series F Preferred Stock.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Roth Capital Partners and Brookline Securities in a $5.5 Million Public Offering of QBIO Med.

    QBioMed

    Press Release – New York, NY – February 1, 2018 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Roth Capital Partners LLC as lead Placement Agent and CIM/Brookline Securities, as Co-Lead Placement Agent in a public offering of Common Stock and Warrants Series for QBIO Med, Inc. (OTC.QBIO). QBIO is a biotechnology acceleration and development company focused on acquiring and in-licensing life science therapeutics products.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $30 Million Above-Market Registered Direct Offering

    vuzix view the future logo

    Press Release – New York, NY – January 26, 2016 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 3,000,000 million registered shares of its common stock at a price of $10.00 per share and 1,200,000 1 year common stock purchase warrants with an exercise price of $10.00 per share  for gross proceeds to Vuzix of $30,000,000. Chardan Capital Markets LLC acted as the exclusive Placement Agent for the offering.  The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia, Thomas Rose, and Counsel Jeff Cahlon. continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Biotricity Inc. in $2.5 Million Registered Direct Offering

    biotricity logo

    Press Release – New York, NY – December 22, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Biotricity Inc. (OTCQB:BTCY”) in a Registered Direct public offering of 450,164 registered shares of its common stock at a price of $5.50 per share for aggregate proceeds of approximately $2.5 million.

    The Sichenzia Ross Ference Kesner LLP team was led by Partners Gregory Sichenzia and David Manno.

    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference Kesner LLP Represents Vuzix Corporation in $12.5 Million Registered Direct Offering

    Vuzix Corporation

    Press Release – New York, NY – December 18, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Vuzix Corporation (NASDAQ “VUZI”) in a Registered Direct public offering of 2,066,116 million registered shares of its common stock at a price of $6.05 per share and 1,033,058 3-year common stock purchase warrants with an exercise price of $7.00 per share  for gross proceeds to Vuzix of $12,500,000.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw, a unit of H.C Wainwright, in a $3.9 Million Public Offering of Medical Transcript Billing, Corp.

    mtbc - medical transcription billing corp. logo

    Press Release – New York, NY – December 11, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $6.58 Million Registered Direct Offering and Concurrent Private Placement

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    Press Release – New York, NY – December 6, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a registered direct offering and private placement offering of 7,151,146 shares of common stock and restricted five-year warrants to purchase up to 7,151,146 shares of common stock exercisable at $1.09 per warrant.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $12.0 Million Firm Commitment Public Offering

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    Press Release – New York, NY – November 9, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it represented Pareteum Corporation (NYSE American: “TEUM”), a leading international provider of mobile networking software and services to the Mobile Network and Internet of Things markets, in a firm commitment underwritten offering of 9,009,478 shares of common stock, 4,034 shares of preferred stock (each of which shares is an equivalent of 920 shares of common stock), and five-year warrants to purchase up to 7,478,228 shares of common stock exercisable at $1.05 per warrant.

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $6.75 Million Registered Direct Offering of Common Stock of Ampio Pharmaceuticals, Inc.

    ampio pharmaceuticals

    Press Release – New York, NY – October 18, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as Lead Placement Agent and Fordham Financial Management Co-Placement Agent  in a $6.75 million Registered Direct Public Offering of Common Stock of Ampio Pharmaceuticals, Inc. (“NYSE.AMPE”).

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Represents Pareteum Corporation in $1.56 Million Shelf Take Down

    The Sichenzia Ross Ference LLP team was led by partners Darrin M. Ocasio and Avital,  Perlman, Counsel Jeffrey Cahlon and associate Grant Levine.

    Press Release – New York, NY – October 12, 2017 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Pareteum Corporation (“Pareteum”), a rapidly growing mobile Cloud Communications Platform company, in connection with its shelf take down of 1,495,000 shares of its common stock. Gross proceeds to Pareteum from this offering are $1,569,750 before deducting placement agent’s commissions and other expenses.  Dawson James Securities acted as placement agent for the offering.

    The Sichenzia Ross Ference Kesner LLP team was led by Partner Darrin M. Ocasio, Counselors Jeffrey Cahlon, and Cheryll J. Calaguio and Associate Evan Berger.

    Sichenzia Ross Ference LLP

    Sichenzia Ross Ference Kesner LLP Represents Rodman & Renshaw a unit of H.C Wainwright in a $6.0 Million Public Offering of Medical Transcript Billing, Corp.

    mtbc.com logo

    Press Release – New York, NY – September 28, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Rodman & Renshaw, a unit of H.C. Wainwright, as Exclusive Placement Agent and Boenning & Scattergood, Inc. as co-placement agent in a public offering of Series A Preferred stock for Medical Transcript Billing, Corp. (MTBC.NASDAQ).

    continue reading >>

    Sichenzia Ross Ference Kesner LLP Real Estate Group Represents One Wall Partners in a $63 Million, 16-Building, Portfolio Acquisition

    one wall partners

    Press Release – New York, NY – September 20, 2017 – The real estate practice group of SRFK announced today that it recently closed on a $63 million, 16 building, multi-family, portfolio acquisition for One Wall Partners.  One Wall Partners is a vertically integrated real estate investment firm that specializes in the acquisition, development and management of transit-oriented workforce housing.  The Sichenzia Ross Ference Kesner LLP team was led by partner Anthony Ficara, counsel Michael Wickersham and associate Laura Kim.

    Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar & Co., LLC in $10 Million Public Offering of American Depository Shares of BiondVax Pharmaceuticals Ltd. (Israel)

    biondvax pharmaceuticals

    Press Release – New York, NY – September 19, 2017 – Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co., LLC. as sole book running manager in the underwritten public offering of American Depository Shares (ADS’s) of BiondVax Pharmaceuticals, Ltd. (NASDAQ: BVXV, TASE BVXV), a clinical stage biopharmaceutical company focused on developing a universal flu vaccine. The public offering consisted of 1,500,000 ADS’s and the full overallotment of 166,667 additional ADS’s at a public offering price of $6.00 per ADS for gross proceeds of $10 million.  The Sichenzia Ross Ference Kesner LLP team was led by partners Gregory Sichenzia and Avital Perlman, Counsel Jeffrey Cahlon and Associate Evan Berger.

    Sichenzia Ross Ference Kesner LLP Represents Aegis Capital Corp. in $6 Million Public Offering of Units of Precipio, Inc.

    precipio diagnostics

    Press Release – New York, NY – August 23rd, 2017 –  Sichenzia Ross Ference Kesner LLP announced today that it has represented Aegis Capital Corp. as sole book running manager in the underwritten public offering of Units of Precipio, Inc. (NASDAQ: PRPO). Each Unit is comprised of 1 share of Series B Preferred Stock which is convertible into 400 shares of common stock at a price of $2.50 per share and one warrant to purchase 400 shares of common stock at $3.00 per share.   Precipio provides diagnostic information to physicians and there patients worldwide.  The Sichenzia Ross Ference Kesner LLP team was led by partner Tom Rose and counsel Jeff Cahlon.

    Sichenzia Ross Ference Kesner LLP Represents Joseph Gunnar and Fordham Financial Management in $11.8 PIPE financing of Aytu Bioscience, Inc.

    aytu bioscience

    Press Release – New York, NY – November 2, 2016 – Nationally recognized securities and corporate law firm Sichenzia Ross Ference Kesner LLP announced today that it has represented Joseph Gunnar & Co.  as lead placement agent and Fordham Financial Management, Inc. co-placement agent  in a private placement offering of equity securities of Aytu BioScience, Inc.  (OTC Market “AYTU”).

    continue reading >>